Scholarlink

In the era of personalized therapies immunotherapy has revolutionized the anticancer treatment. Target therapies are directed against a specific proliferative pathway. However, in the recent years both immunotherapy and biologic therapies have overcome the primary cancer histology and a wide range of clinical indications accounts for different solid tumors.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Beyond Histology and Stage: The “Signatures” to Personalize Immunotherapy

  • 工具书词条

  • 发表日期：

    2025年

查看全文
  • Nerina Denaro,
  • Marco Carlo Merlano,
  • Andrea Abbona,
  • Matteo Paccagnella,
  • Ornella Garrone

摘要

In the era of personalized therapies immunotherapy has revolutionized the anticancer treatment. Target therapies are directed against a specific proliferative pathway. However, in the recent years both immunotherapy and biologic therapies have overcome the primary cancer histology and a wide range of clinical indications accounts for different solid tumors.